- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04594057
Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy
The Impact of Vestibular Rehabilitation on the Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this project we will focus on characterizing deficits in community-based performance (i.e., head and trunk control during simulated community activities, short term community mobility, and patient reported participation) and relating these deficits to laboratory (i.e., video head impulse testing and corrective postural responses) and clinical (i.e., MiniBEST and dynamic visual acuity, and visual spatial cognition) measures of gaze and postural stability in individuals with varied forms of vestibulopathy (unilateral vestibular neuritis, bilateral vestibular loss, migraine related vestibulopathy, concussion, BPPV, Multiple Sclerosis). Additionally, we will examine the longitudinal change of laboratory, and community-based measures of gaze and postural in two cohorts of people with a specific form of unilateral vestibular loss (Vestibular Schwannoma resection); one group of these individuals will receive 6 weeks of vestibular rehabilitation during the acute onset of symptoms and the other one will begin intervention 6 weeks post onset. This portion of the proposed project will test my global hypothesis that changes in community-based performance of head and trunk control impair recovery following the onset of VH.
Aim 1: In individuals with vestibulopathy, characterize and compare laboratory and clinical measures of body structure, function, and performance to community-based, activity levels, performance, and patient reported participation. Hypothesis 1: The severity of laboratory and clinically measured gaze and postural stability function deficits will not strongly correlate with head and trunk control during community-based performance or patient reported participation. Hypothesis 2: The nature and severity of laboratory and clinically measured gaze and postural stability function deficits will differ between varied diagnostic groups.
Aim 2: In individuals with unilateral vestibular hypofunction following unilateral vestibular schwannoma resection, examine the longitudinal trajectories of laboratory and clinical measures of body structure, function and performance, and community-based performance, activity levels, and patient reported participation during periods of spontaneous and rehabilitation driven recovery. Hypothesis: Recovery of laboratory and clinical measures will follow different trajectories than measures of community-based performance and patient reported participation during both periods of spontaneous and rehabilitation driven recovery.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Brian Loyd, PhD
- Phone Number: 801-587-3181
- Email: brian.loyd@health.utah.edu
Study Contact Backup
- Name: Lee Dibble, PhD
- Phone Number: 801-587-3181
- Email: lee.dibble@hsc.utah.edu
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84108
- Recruiting
- University of Utah
-
Contact:
- Brian Loyd, PhD
- Phone Number: 801-587-3181
- Email: brian.loyd@health.utah.edu
-
Contact:
- Lee Dibble, PhD
- Phone Number: 801-587-3181
- Email: lee.dibble@hsc.utah.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Reports of dizziness as indicated by Dizziness handicap inventory score >0
- Undergoing a vestibular schwannoma resection surgery and/or vestibular hypofunction diagnosed using bedside examination
- Able to perform community ambulation
Exclusion Criteria:
- Presence of cardiovascular, orthopedic, or other neurologic diagnosis that limits ability to complete study testing, or causes other forms of dizziness.
- Blindness
- Peripheral neuropathy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Early Start
Begin 6 weeks of gaze and postural stability training 10-14 days following surgery.
|
Gaze and Postural Stability The duration and content of the Gaze and Postural Stability (GPS) intervention is specifically designed to focus on gradually increasing difficulty of gaze and postural stability exercises. The target duration of each in clinic visit will be 90 min (15 min of gaze stability exercises, 15 min of postural stability exercises and approximately 60 min for the standard care control intervention with rest interspersed throughout the exercise session. Gaze stability exercise will consist of progressive Vestibular-occular training. Postural stability exercises will consist of progressive static and dynamic postural training. |
Experimental: Delayed Start
Begin 6 weeks of gaze and postural stability training 6 weeks following surgery.
|
Gaze and Postural Stability The duration and content of the Gaze and Postural Stability (GPS) intervention is specifically designed to focus on gradually increasing difficulty of gaze and postural stability exercises. The target duration of each in clinic visit will be 90 min (15 min of gaze stability exercises, 15 min of postural stability exercises and approximately 60 min for the standard care control intervention with rest interspersed throughout the exercise session. Gaze stability exercise will consist of progressive Vestibular-occular training. Postural stability exercises will consist of progressive static and dynamic postural training. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Dizziness Handicap Inventory (DHI)
Time Frame: Change baseline to 6 weeks
|
Dizziness Handicap Inventory (DHI): The DHI is a self assessment inventory designed to evaluate the self-perceived handicap effects imposed by dizziness or unsteadiness and has documented test-retest and internal consistency reliability in PwMS.
The DHI consists of 25 questions subgroup into functional, emotional, and physical components.
The total score ranges from 0-100, with higher scores indicating greater handicap.
Change from baseline to 6 weeks post surgery.
|
Change baseline to 6 weeks
|
Change in miniBEST test
Time Frame: Change from baseline to 6 weeks
|
the 14-item Mini-BESTest which includes four sections (anticipatory postural adjustments, reactive postural responses, sensory orientation, and stability in gait) relevant to postural control and stability in MS.
The maximum possible score is 28 with higher scores indicating better balance.
Tasks within the Mini-BEST test require head and/ or body motion, which will be assessed using body-worn 3D accelerometers.
The Change from the baseline score to the 6 weeks post surgery score.
|
Change from baseline to 6 weeks
|
Change in Community-simulated Ambulatory Task (CAT)
Time Frame: Change from Baseline to 6 weeks
|
Community-simulated walking task consisting of turns, stairs, and inside/outside ambulation requiring specific use of head and trunk turns.
Change from baseline to 6 weeks post surgery.
|
Change from Baseline to 6 weeks
|
Change in Passive Angular Vestibular Reflex Testing
Time Frame: Change from Baseline to 6 weeks
|
The angular vestibular ocular reflex (aVOR) gain will be calculated as the ratio of the de-saccaded eye velocity Area Under the Curve (AUC) over the head velocity AUC between the onset of the head impulse to the moment when head velocity returns to zero.
Change from baseline to 6 weeks post surgery in aVOR gain.
|
Change from Baseline to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Activities Balance Confidence Scale (ABC)
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The Activity Specific Balance Confidence Scale (ABC) is a 16-item self-reported measure of balance confidence in performing various activities of daily living.
Each question requires an individual to grade his or her self on a scale of 0 to 100 percent for their level of confidence and higher scores indicate greater balance confidence in performing these activities.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Life Space Assessment
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The Life Space Assessment is self-report questionnaire that captures the amount of time which a person interacts with differing levels of their environment.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Dynamic Visual Acuity
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The Dynamic Visual Acuity (DVA) test is a valid and reliable functional measure of gaze stability that utilizes head rotations representing natural head velocities during daily activities.
The variable logMAR is the standard measurement for DVA and is equal to log10x, where x is the minimum angle resolved, in arcmin, with 1 arcmin equal to 1/60°).
The better one's visual acuity, the lower one's logMAR score.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Compensatory Saccade Frequency
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The number of Compensatory Saccades (CS) per Head Rotation (CS/HR) will be manually counted per head rotation.
Collected at intervention completion and 1-month follow-up adjusting for baseline (values collected at baseline assessment).
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Daily Step Activity
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Step activity monitors will be used to quantify daily step activity during over a 4 day window.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Postural Sway
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The amount of postural sway during quiet stance on firm, foam, and incline surfaces will be assessed using 3D accelerometers.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Modified Physical Performance Test (mPPT)
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The mPPT assess basic and complex activities of daily living including rising from a chair, picking an object up from the floor, donning and doffing a jacket, placing an item on a shelf, a 50 foot walk, 360 degree turns, and ascending an descending stairs.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Repeated Battery of the Assessment of Neuropsychological Status (RBANS): Line Orientation Sub-Test
Time Frame: Baseline, 10 days post surgery, and 12 weeks post surgery.
|
A test of visual spatial cognition that requires the participant to try and correctly identify the orientation of two lines presented to them with 12 other line options.
Scores range from 0-20 based on correctness of line orientation on 10 different trials.
|
Baseline, 10 days post surgery, and 12 weeks post surgery.
|
Repeated Battery of the Assessment of Neuropsychological Status (RBANS): Figure Copy Sub-Test
Time Frame: Baseline, 10 days post surgery, and 12 weeks post surgery.
|
A test of visual spatial cognition that requires the participant to copy a multiple shape figure and is scored from 0-20 based on the correctness of the figure copy.
|
Baseline, 10 days post surgery, and 12 weeks post surgery.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Two-Minute Walk (2MWT)
Time Frame: Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
The distance walked in 2 minutes (Two-Minute Walk [2MWT]) is a valid and reliable measure of locomotor ability in populations with a variety of chronic diseases.
Higher values reflect greater ability.
|
Baseline, 10 days post surgery, 6 weeks, and 12 weeks post surgery.
|
Visual Analog Scale of Dizziness
Time Frame: Baseline, 10 days post surgery, 3 weeks, 6 weeks, 9 weeks, and 12 weeks post surgery.
|
A single mark will be made along a 10 cm line indicating the amount of dizziness experienced ranging from "no dizziness" to "worst possible dizziness".
|
Baseline, 10 days post surgery, 3 weeks, 6 weeks, 9 weeks, and 12 weeks post surgery.
|
Visual Analog Scale of Unsteadiness
Time Frame: Baseline, 10 days post surgery, 3 weeks, 6 weeks, 9 weeks, and 12 weeks post surgery.
|
A single mark will be made along a 10 cm line indicating the amount of unsteadiness experienced ranging from "no unsteadiness" to "worst possible unsteadiness".
|
Baseline, 10 days post surgery, 3 weeks, 6 weeks, 9 weeks, and 12 weeks post surgery.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Otorhinolaryngologic Neoplasms
- Otorhinolaryngologic Diseases
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Labyrinth Diseases
- Ear Diseases
- Nervous System Neoplasms
- Cranial Nerve Diseases
- Neuroendocrine Tumors
- Nerve Sheath Neoplasms
- Peripheral Nervous System Neoplasms
- Cranial Nerve Neoplasms
- Neuroma
- Vestibulocochlear Nerve Diseases
- Retrocochlear Diseases
- Vestibular Diseases
- Neurilemmoma
- Neuroma, Acoustic
Other Study ID Numbers
- IRB_00125069
- NIFTI (Other Grant/Funding Number: Foundation for Physical Therapy)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vestibular Schwannoma
-
Assistance Publique - Hôpitaux de ParisWithdrawnPatient Operated on From a Vestibular Schwannoma With a Middle Ear Exclusion
-
Johns Hopkins UniversityNational Aeronautics and Space Administration (NASA)RecruitingMotion Sickness | Vestibular Schwannoma | Vestibular Disorder | Space Motion SicknessUnited States
-
Charles University, Czech RepublicCompletedVestibular Schwannoma | Vestibular Function DisorderCzechia
-
Massachusetts Eye and Ear InfirmaryOregon Health and Science University; National Institute on Deafness and Other... and other collaboratorsEnrolling by invitationMigraine | Dizziness | Motion Sickness | Vestibular Migraine | Vestibular Schwannoma | Vestibular DisorderUnited States
-
University Health Network, TorontoNovartisTerminated
-
Charles University, Czech RepublicRecruitingAcute Peripheral Vestibulopathy Following Surgical ProcedureCzechia
-
Emory UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedVestibular Schwannoma | Vestibular Neuronitis | Vestibular Neuronitis, BilateralUnited States
-
University Hospital, MotolCompleted
-
University of Alabama at BirminghamMemorial Sloan Kettering Cancer CenterActive, not recruitingNeurofibromatosis 2 | Progressive Vestibular Schwannoma (VS)United States
-
Assistance Publique Hopitaux De MarseilleCompletedVisual Impairment | Vestibular Schwannoma | Vestibular Meniere SyndromeFrance
Clinical Trials on Gaze and Postural Retraining Exercise
-
University of UtahJohns Hopkins University; Arizona State University; National Multiple Sclerosis...CompletedMultiple Sclerosis | Vertigo | Dizziness | Falls InjuryUnited States
-
Emory UniversityNational Institute of Nursing Research (NINR)CompletedHeart FailureUnited States
-
VA Office of Research and DevelopmentCompleted
-
US Department of Veterans AffairsCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Meir Medical CenterCompletedChildhood ObesityIsrael
-
US Department of Veterans AffairsCompleted
-
Cairo UniversityCompletedCervical Myofascial Pain SyndromeEgypt
-
Laval UniversityCompletedPatellofemoral Pain (PFPS)Canada